Today: 9 April 2026
Bloom Energy stock jumps 12% today as fuel-cell rally returns — what to watch next

Bloom Energy stock jumps 12% today as fuel-cell rally returns — what to watch next

New York, Jan 2, 2026, 12:33 ET — Regular session

  • Bloom Energy shares climb about 12% in midday trading, leading gains among U.S.-listed fuel-cell names.
  • Plug Power, Ballard Power Systems and FuelCell Energy also rise sharply.
  • Investors are watching next week’s macro catalysts and signs of follow-through in data-center power demand.

Bloom Energy Corporation shares rose about 12% in midday trading on Friday. The stock was last up $10.09, or 11.6%, at $96.98. It traded between $88.84 and $97.30.

The move matters now because Bloom has become a high-beta proxy for the “AI power” trade — the idea that data-center buildouts will push customers toward faster-to-install, on-site generation. A strong first-week bid can reset positioning after late-December volatility in the group.

Friday’s rally also landed as investors sized up early-2026 macro catalysts, with attention on the U.S. jobs report due Jan. 9 and how the data could shape interest-rate expectations. Reuters also flagged looming risks including a U.S. Supreme Court ruling on Trump-era tariffs and the expected announcement of a new Federal Reserve chair.

Bloom sells solid oxide fuel-cell systems that generate electricity through an electrochemical process rather than combustion. The company pitches the technology as a way to add capacity quickly for customers that cannot wait for new grid connections.

A core concept in the story is “behind-the-meter” power — electricity generated on the customer’s side of the utility meter. In plain terms, it can reduce reliance on the grid and shorten the timeline from order to power.

Bloom has tied that pitch to large data-center customers and financiers. The company said in July it would deploy its fuel-cell systems at selected Oracle Cloud Infrastructure data centers in the United States, and in October it said Brookfield would invest up to $5 billion to deploy Bloom’s technology for “AI factories.” Bloom Energy

Brookfield has framed AI power demand as a once-in-a-generation buildout. Sikander Rashid, its head of AI infrastructure, said AI is creating “one of the largest infrastructure build outs in history” and would require $7 trillion of capital over the next decade, according to Reuters. Reuters

Bloom’s jump came with broad gains across the fuel-cell complex. Plug Power rose about 14%, Ballard Power Systems gained about 8%, and FuelCell Energy climbed about 11%.

The sector move suggests investors are leaning back into higher-volatility clean-energy names as the new year starts, rather than reacting to a single company headline. For Bloom, that tends to amplify both upside momentum and downside air pockets.

Technically, traders were watching whether the stock could sustain a move toward the $100 mark, a level that often draws attention in short-term trading. A retreat toward the prior close area in the high-$80s would put Friday’s bounce back on trial.

On the company calendar, Bloom says it will appear at PowerGen International in San Antonio on Jan. 20-22, with sessions focused on behind-the-meter generation and data-center applications. Bloom Energy

Investors are likely to keep the focus on order timing, capacity additions and service margins — the details that determine whether fast growth translates into durable cash generation. The big data-center tie-ups have set a high bar for the next round of results and guidance.

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:14 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
GE Vernova stock jumps 3% as grid-buildout trade regains focus heading into dividend date
Previous Story

GE Vernova stock jumps 3% as grid-buildout trade regains focus heading into dividend date

ServiceNow (NOW) stock drops more than 3% today as software shares slide; jobs report in focus
Next Story

ServiceNow (NOW) stock drops more than 3% today as software shares slide; jobs report in focus

Go toTop